Mail

UK markets close in 5 hours 4 minutes

FTSE 100
8,300.59
+87.10(+1.06%)
FTSE 250
20,389.37
+224.83(+1.11%)
AIM
777.14
+5.61(+0.73%)
GBP/EUR
1.1647
-0.0012(-0.10%)
GBP/USD
1.2539
-0.0025(-0.20%)
Bitcoin GBP
50,921.40
-858.18(-1.66%)

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

5.95

-0.11

(-1.82%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	3.05B
Enterprise value	2.87B
Trailing P/E	14.64
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.18
Price/book (mrq)	1.50
Enterprise value/revenue	2.99
Enterprise value/EBITDA	12.23

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-10.22%
S&P500 52-week change ³	24.49%
52-week high ³	7.38
52-week low ³	4.08
50-day moving average ³	5.38
200-day moving average ³	6.33

Share statistics

Avg vol (3-month) ³	11.63M
Avg vol (10-day) ³	14M
Shares outstanding ⁵	503.2M
Implied shares outstanding ⁶	503.2M
Float ⁸	249.41M
% held by insiders ¹	53.29%
% held by institutions ¹	2.65%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.3
Forward annual dividend yield ⁴	4.95%
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	72.50%
Dividend date ³	N/A
Ex-dividend date ⁴	20 Jun 2023
Last split factor ²	1.7:1
Last split date ³	30 May 2019

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	21.70%
Operating margin (ttm)	24.98%

Management effectiveness

Return on assets (ttm)	5.03%
Return on equity (ttm)	10.46%

Income statement

Revenue (ttm)	959.39M
Revenue per share (ttm)	1.91
Quarterly revenue growth (yoy)	1.50%
Gross profit (ttm)	N/A
EBITDA	242.2M
Net income avi to common (ttm)	208.21M
Diluted EPS (ttm)	0.41
Quarterly earnings growth (yoy)	5.80%

Balance sheet

Total cash (mrq)	273.82M
Total cash per share (mrq)	0.54
Total debt (mrq)	95.12M
Total debt/equity (mrq)	4.69%
Current ratio (mrq)	2.77
Book value per share (mrq)	4.03

Cash flow statement

Operating cash flow (ttm)	111M
Levered free cash flow (ttm)	39.45M